194 related articles for article (PubMed ID: 37704601)
21. Nitroimidazole derivative incorporated liposomes for hypoxia-triggered drug delivery and enhanced therapeutic efficacy in patient-derived tumor xenografts.
Li Y; Lu A; Long M; Cui L; Chen Z; Zhu L
Acta Biomater; 2019 Jan; 83():334-348. PubMed ID: 30366135
[TBL] [Abstract][Full Text] [Related]
22. Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cancer.
Nicholas D; Nesbitt H; Farrell S; Logan K; McMullin E; Gillan T; Kelly P; O'Rourke D; Porter S; Thomas K; O'Hagan BMG; Nomikou N; Callan B; Callan JF; McHale AP
Eur J Pharm Biopharm; 2021 Jun; 163():49-59. PubMed ID: 33798727
[TBL] [Abstract][Full Text] [Related]
23. Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma.
Li Y; Zhao Z; Liu H; Fetse JP; Jain A; Lin CY; Cheng K
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45390-45403. PubMed ID: 31769963
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal PET Imaging to Monitor Treatment Efficacy by Liposomal Irinotecan in Orthotopic Patient-Derived Pancreatic Tumor Models of High and Low Hypoxia.
Ventura M; Bernards N; De Souza R; Fricke IB; Hendriks BS; Fitzgerald JB; Lee H; Klinz SG; Zheng J
Mol Imaging Biol; 2020 Jun; 22(3):653-664. PubMed ID: 31482415
[TBL] [Abstract][Full Text] [Related]
25. Enhanced pancreatic cancer gene therapy by combination of adenoviral vector expressing c-erb-B2 (Her-2/neu)-targeted immunotoxin with a replication-competent adenovirus or etoposide.
Liu X; Li J; Tian Y; Xu P; Chen X; Xie K; Qiu Z; Wang Y; Zhang D; Wolf F; Li C; Huang Q
Hum Gene Ther; 2010 Feb; 21(2):157-70. PubMed ID: 19751100
[TBL] [Abstract][Full Text] [Related]
26. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
27. Targeting hypoxic tumor microenvironment in pancreatic cancer.
Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
[TBL] [Abstract][Full Text] [Related]
28. Deep-Penetrating Triple-Responsive Prodrug Nanosensitizer Actuates Efficient Chemoradiotherapy in Pancreatic Ductal Adenocarcinoma Models.
Tang X; Du X; Yu Y; Qin M; Qian L; Zhang M; Yang Y; Yu Q; Gan Z
Small; 2022 Aug; 18(31):e2202834. PubMed ID: 35808966
[TBL] [Abstract][Full Text] [Related]
29. MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression.
Zhu S; He C; Deng S; Li X; Cui S; Zeng Z; Liu M; Zhao S; Chen J; Jin Y; Chen H; Deng S; Liu Y; Wang C; Zhao G
Mol Cancer Ther; 2016 Sep; 15(9):2209-19. PubMed ID: 27353169
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer.
Sun JD; Liu Q; Ahluwalia D; Li W; Meng F; Wang Y; Bhupathi D; Ruprell AS; Hart CP
Cancer Biol Ther; 2015; 16(3):438-49. PubMed ID: 25679067
[TBL] [Abstract][Full Text] [Related]
31. Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302.
Lohse I; Rasowski J; Cao P; Pintilie M; Do T; Tsao MS; Hill RP; Hedley DW
Oncotarget; 2016 Jun; 7(23):33571-80. PubMed ID: 27248663
[TBL] [Abstract][Full Text] [Related]
32. A novel fusicoccin derivative preferentially targets hypoxic tumor cells and inhibits tumor growth in xenografts.
Kawakami K; Hattori M; Inoue T; Maruyama Y; Ohkanda J; Kato N; Tongu M; Yamada T; Akimoto M; Takenaga K; Sassa T; Suzumiy J; Honma Y
Anticancer Agents Med Chem; 2012 Sep; 12(7):791-800. PubMed ID: 22263802
[TBL] [Abstract][Full Text] [Related]
33. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.
Harashima N; Takenaga K; Akimoto M; Harada M
Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028
[TBL] [Abstract][Full Text] [Related]
34. MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts.
Zhang X; Wojtkowiak JW; Martinez GV; Cornnell HH; Hart CP; Baker AF; Gillies R
PLoS One; 2016; 11(5):e0155289. PubMed ID: 27227903
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers.
Zhang H; Cao K; Xiang J; Zhang M; Zhu M; Xi Q
Cancer Lett; 2023 Sep; 571():216345. PubMed ID: 37558084
[TBL] [Abstract][Full Text] [Related]
36. VEGF-RII influences the prognosis of pancreatic cancer.
Büchler P; Reber HA; Büchler MW; Friess H; Hines OJ
Ann Surg; 2002 Dec; 236(6):738-49; discussion 749. PubMed ID: 12454512
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition.
Shi X; Wang M; Zhang Y; Guo X; Liu M; Zhou Z; Zhao Y; He R; Gao Y; Liu Y; Pan S; Zhou M; Zhao C; Yin T; Li X; Wang H; Yang J; Zhu F; Li M; Qin R
EBioMedicine; 2022 Dec; 86():104352. PubMed ID: 36371988
[TBL] [Abstract][Full Text] [Related]
38. Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model.
Büchler P; Reber HA; Lavey RS; Tomlinson J; Büchler MW; Friess H; Hines OJ
J Surg Res; 2004 Aug; 120(2):295-303. PubMed ID: 15234226
[TBL] [Abstract][Full Text] [Related]
39. Distribution of Gemcitabine Is Nearly Homogenous in Two Orthotopic Murine Models of Pancreatic Cancer.
Kramer RM; Russell J; Humm JL
Cancer Biother Radiopharm; 2015 Sep; 30(7):299-304. PubMed ID: 26203552
[TBL] [Abstract][Full Text] [Related]
40. An Antitumor Dual-Responsive Host-Guest Supramolecular Polymer Based on Hypoxia-Cleavable Azocalix[4]arene.
Yao SY; Yue YX; Ying AK; Hu XY; Li HB; Cai K; Guo DS
Angew Chem Int Ed Engl; 2023 Jan; 62(2):e202213578. PubMed ID: 36353747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
